CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,969,432 | -31.1% | 1,183,198 | -1.4% | 0.00% | -50.0% |
Q4 2022 | $7,212,439 | +80603.1% | 1,200,073 | -21.8% | 0.00% | 0.0% |
Q3 2022 | $8,937 | +131.2% | 1,535,544 | +137.1% | 0.00% | +100.0% |
Q2 2022 | $3,866 | -99.8% | 647,596 | +85.5% | 0.00% | – |
Q1 2022 | $1,631,000 | +973.0% | 349,175 | +472.0% | 0.00% | – |
Q4 2021 | $152,000 | +46.2% | 61,047 | +46.9% | 0.00% | – |
Q2 2021 | $104,000 | -43.8% | 41,558 | -27.8% | 0.00% | – |
Q4 2020 | $185,000 | +781.0% | 57,586 | +338.5% | 0.00% | – |
Q4 2019 | $21,000 | -93.6% | 13,131 | -96.5% | 0.00% | – |
Q2 2019 | $326,000 | +3975.0% | 379,279 | +3264.8% | 0.00% | – |
Q4 2018 | $8,000 | -77.1% | 11,272 | -30.5% | 0.00% | – |
Q3 2018 | $35,000 | -91.5% | 16,208 | -80.4% | 0.00% | – |
Q2 2018 | $412,000 | -75.0% | 82,738 | -80.4% | 0.00% | – |
Q1 2018 | $1,650,000 | +2042.9% | 422,954 | +1706.6% | 0.00% | – |
Q2 2017 | $77,000 | -64.4% | 23,412 | -54.4% | 0.00% | – |
Q1 2017 | $216,000 | – | 51,355 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 4,684,404 | $21,876,000 | 9.07% |
Lion Point Capital, LP | 5,489,546 | $25,636,000 | 5.95% |
SILVERARC CAPITAL MANAGEMENT, LLC | 2,250,000 | $10,508,000 | 4.35% |
Bleichroeder LP | 3,859,707 | $18,025,000 | 3.20% |
NEA Management Company, LLC | 7,140,450 | $99,804,000 | 2.88% |
BVF INC/IL | 8,929,690 | $41,702,000 | 1.67% |
Ghost Tree Capital, LLC | 1,300,000 | $6,071,000 | 1.32% |
EAM Investors, LLC | 1,011,935 | $4,726,000 | 0.88% |
Knott David M Jr | 556,687 | $2,600,000 | 0.83% |
Sofinnova Investments, Inc. | 1,952,691 | $9,119,000 | 0.69% |